Cerenome is trading at $1.79, up 6.55%, with healthcare-sector strength a possible tailwind. - Healthcare shares are rising amid inflation concerns and strong healthcare earnings. - No clear company-specific announcement explaining the October 15 move was found; the latest listed releases were the October 6 test launch and October 8 Florida Blue agreement. Broader indexes were mixed, making sector strength a better fit than a broad-market rally.